Wordt geladen...
The Mitochondrial Protease LonP1 Promotes Proteasome Inhibitor Resistance in Multiple Myeloma
SIMPLE SUMMARY: Multiple myeloma is the second most common cancer of the blood system in the US. Despite new therapies, a cure remains elusive, and current drugs inevitably become ineffective due to various resistance mechanisms. A frontline clinical strategy is the inhibition of the proteasome, the...
Bewaard in:
| Gepubliceerd in: | Cancers (Basel) |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7922145/ https://ncbi.nlm.nih.gov/pubmed/33671345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13040843 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|